It's because whilst people need patience in the bio world, RAC has wasted quite a bit of time without dosing a patient and then nearly starting again.
The drug may be wonderful (and almost certainly is) but management haven't proven themselves to the market to be able to commercialize it, complete trials, stay on the path etc.
Outstanding opportunity but we're down to well under 2021 prices. People can only take so much mismanagement before the trend and market is hard to fight against
Long time holder, been in since Jan 2020, and participated in the SPP, will convert options etc but yeah, I completely understand why the SP is where it is. Will take more to convert the market towards RAC now than it would have in 2021 too (hope that makes sense)
It's because whilst people need patience in the bio world, RAC...
-
- There are more pages in this discussion • 3,141 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.70 |
Change
0.090(5.59%) |
Mkt cap ! $289.5M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.76 | $1.59 | $142.7K | 84.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17175 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.77 | 6060 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |